BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10694553)

  • 1. TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors.
    Grotzer MA; Janss AJ; Fung K; Biegel JA; Sutton LN; Rorke LB; Zhao H; Cnaan A; Phillips PC; Lee VM; Trojanowski JQ
    J Clin Oncol; 2000 Mar; 18(5):1027-35. PubMed ID: 10694553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors.
    Grotzer MA; Janss AJ; Phillips PC; Trojanowski JQ
    Klin Padiatr; 2000; 212(4):196-9. PubMed ID: 10994550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.
    Grotzer MA; Hogarty MD; Janss AJ; Liu X; Zhao H; Eggert A; Sutton LN; Rorke LB; Brodeur GM; Phillips PC
    Clin Cancer Res; 2001 Aug; 7(8):2425-33. PubMed ID: 11489822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative mRNA expression analysis of neurotrophin-receptor TrkC and oncogene c-MYC from formalin-fixed, paraffin-embedded primitive neuroectodermal tumor samples.
    Kunz F; Shalaby T; Lang D; von Büren A; Hainfellner JA; Slavc I; Tabatabai G; Grotzer MA
    Neuropathology; 2006 Oct; 26(5):393-9. PubMed ID: 17080715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
    Biegel JA; Janss AJ; Raffel C; Sutton L; Rorke LB; Harper JM; Phillips PC
    Clin Cancer Res; 1997 Mar; 3(3):473-8. PubMed ID: 9815707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas.
    Huber H; Eggert A; Janss AJ; Wiewrodt R; Zhao H; Sutton LN; Rorke LB; Phillips PC; Grotzer MA
    Eur J Cancer; 2001 Nov; 37(16):2064-72. PubMed ID: 11597385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome.
    Scheurlen WG; Schwabe GC; Joos S; Mollenhauer J; Sörensen N; Kühl J
    J Clin Oncol; 1998 Jul; 16(7):2478-85. PubMed ID: 9667267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotrophin and neurotrophin receptor proteins in medulloblastomas and other primitive neuroectodermal tumors of the pediatric central nervous system.
    Washiyama K; Muragaki Y; Rorke LB; Lee VM; Feinstein SC; Radeke MJ; Blumberg D; Kaplan DR; Trojanowski JQ
    Am J Pathol; 1996 Mar; 148(3):929-40. PubMed ID: 8774147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors.
    Janss AJ; Yachnis AT; Silber JH; Trojanowski JQ; Lee VM; Sutton LN; Perilongo G; Rorke LB; Phillips PC
    Ann Neurol; 1996 Apr; 39(4):481-9. PubMed ID: 8619526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of Ki-67 (MIB-1) proliferation index in childhood primitive neuroectodermal tumors of the central nervous system.
    Grotzer MA; Geoerger B; Janss AJ; Zhao H; Rorke LB; Phillips PC
    Med Pediatr Oncol; 2001 Feb; 36(2):268-73. PubMed ID: 11452934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91.
    Rutkowski S; von Bueren A; von Hoff K; Hartmann W; Shalaby T; Deinlein F; Warmuth-Metz M; Soerensen N; Emser A; Bode U; Mittler U; Urban C; Benesch M; Kortmann RD; Schlegel PG; Kuehl J; Pietsch T; Grotzer M
    Clin Cancer Res; 2007 May; 13(9):2651-7. PubMed ID: 17473196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma.
    Miller S; Rogers HA; Lyon P; Rand V; Adamowicz-Brice M; Clifford SC; Hayden JT; Dyer S; Pfister S; Korshunov A; Brundler MA; Lowe J; Coyle B; Grundy RG
    Neuro Oncol; 2011 Aug; 13(8):866-79. PubMed ID: 21798848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of FLI-1 and analysis of prognostic factors in primitive neuroectodermal tumor].
    Chen LJ; Jia YX; Fan FF; Li XY
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):917-20. PubMed ID: 21223800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tropomyosin receptor kinase C (TrkC) expression in medulloblastoma: relation to the molecular subgroups and impact on treatment response.
    Friedrich C; Shalaby T; Oehler C; Pruschy M; Seifert B; Picard D; Remke M; Warmuth-Metz M; Kortmann RD; Rutkowski S; Grotzer MA; von Bueren AO
    Childs Nerv Syst; 2017 Sep; 33(9):1463-1471. PubMed ID: 28695340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.
    Marchetti D; Mrak RE; Paulsen DD; Sinnappah-Kang ND
    J Exp Clin Cancer Res; 2007 Mar; 26(1):5-23. PubMed ID: 17550129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High microvessel density in primitive neuroectodermal brain tumors of childhood.
    Grotzer MA; Wiewrodt R; Janss AJ; Zhao H; Cnaan A; Sutton LN; Rorke LB; Phillips PC
    Neuropediatrics; 2001 Apr; 32(2):75-9. PubMed ID: 11414647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.
    Wolter M; Reifenberger J; Sommer C; Ruzicka T; Reifenberger G
    Cancer Res; 1997 Jul; 57(13):2581-5. PubMed ID: 9205058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primitive neuroectodermal tumors of the central nervous system associated with genetic and metabolic defects.
    Varan A; Yazici N; Akalan N; Yalcin B; Akyüz C; Kutluk T; Büyükpamukçu M
    J Neurosurg Sci; 2012 Mar; 56(1):49-53. PubMed ID: 22415382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastoma.
    Grotzer MA; von Hoff K; von Bueren AO; Shalaby T; Hartmann W; Warmuth-Metz M; Emser A; Kortmann RD; Kuehl J; Pietsch T; Rutkowski S
    Klin Padiatr; 2007; 219(6):312-7. PubMed ID: 18050040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.
    Bayani J; Zielenska M; Marrano P; Kwan Ng Y; Taylor MD; Jay V; Rutka JT; Squire JA
    J Neurosurg; 2000 Sep; 93(3):437-48. PubMed ID: 10969942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.